David Bautista Erazo
Co-founder & CSO
We train the immune system to resolve chronic inflammation.
Our Purpose
We live longer than ever, but not always better. Chronic inflammation quietly steals our healthy years. We're here to achieve a world without chronic inflammation.
The Problem
Chronic inflammation. The root cause of many diseases.
Current pills manage symptoms, not the root cause. You end up managing pills: one for blood pressure, one for cholesterol, one for glucose. Your chart says stable. But the root, an immune system stuck “on,” keeps driving damage year after year.
-
Cardiovascular disease
-
Metabolic disease & fatty liver
-
Neurodegenerative disease
-
Autoimmune disease
The Approach
Not another way to suppress inflammation. A way to resolve it.
Every treatment for chronic inflammation today does one of two things: manage the symptoms, or suppress the immune system to hold it down. Neither resolves what’s driving it.
Solida is a different class. Instead of suppressing the immune system, we train it to resolve the inflammation itself.
Pipeline
One platform. A growing pipeline.
SO001
★ Lead ProgramMASH · Lead Indication
SO002
SO003
People
Immunology, chemistry, and business. In one team.
Nicolás Capaccio
Co-founder & CEO
José Robinson Ramírez Pineda
Co-founder & Immunology Lead
Érika Caro Gómez
Co-founder & Immunology Lead
Eliana Gallego
Co-founder & COO
Backed by 
Let’s talk.
Whether you’re an investor, a potential partner, or a scientist who wants to understand what we’re building. We’d like to hear from you.